Protective role of adenosine A2AR receptor (A2AR) and AC-cAMP-PKA signaling against nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) possibly via its actions on adipocytes is well known in the past decade. Thus, this study evaluates pharmacological activities of A2AR agonist PSB0777, which has already demonstrated to treat NASH. In this study, the inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR with A2AR agonist PSB0777 improves the hepatic and cardiac dysfunction of high-fat diet (HFD)-induced NASH mice.
Pulmonary embolism (PE) after coronary artery bypass grafting (CABG) is a rare but high-risk event. Management is challenging when PE occurs with heparin-induced thrombocytopenia (HIT), limiting thrombolytic and heparin-based strategies. A 59-year-old man developed hypoxemic respiratory failure within 2 weeks after CABG. Computed tomography angiography demonstrated bilateral main and lobar PEs with right-heart strain. HIT was confirmed by studies. Given recent surgery and active HIT, thrombolysis and heparin were contraindicated. He underwent urgent bilateral large-bore mechanical thrombectomy with intraprocedural bivalirudin, resulting in clot reduction and respiratory failure resolution. This case demonstrates the feasibility of large-bore mechanical thrombectomy with bivalirudin for post-CABG intermediate- to high-risk PE with HIT. Published experience with exclusive bivalirudin during large-bore pulmonary thrombectomy remains limited, and this case adds to the evidence for postsurgical PE management. Large-bore mechanical thrombectomy may provide effective reperfusion when thrombolysis is contraindicated, with bivalirudin serving as a nonheparin anticoagulant in active HIT.